GH1 and metabolic dysfunction-associated steatotic liver disease: In addition to well-recognized metabolic risk factors, a growing body of evidence implicates endocrine dysregulation—such as deficiencies in growth hormone (GH), sex hormones, and thyroid hormones as well as hypercortisolemia—in the development and progression of MASLD [9,10].